Tailoring treatments using treatment effect modification

A F Schmidt1,2,3,4, O H Klungel1,2, M Nielen3

  • 1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

Abstract

Insights

Treatment effect modification, a difference in response between patient groups, should be expected in clinical studies. Tailoring treatments to specific patient subgroups can improve outcomes when generalizability is not confirmed.

Area of Science:

  • Biostatistics
  • Clinical Epidemiology
  • Pharmacology

Background:

  • Applying clinical study results to individual patients is challenging.
  • Treatment effect modification (interaction) is defined as differing treatment responses across patient groups.

Purpose of the Study:

  • To discuss the expectation and application of treatment effect modification.
  • To explore methods for tailoring treatment effects to patient needs.

Main Methods:

  • Argument for expecting treatment effect modification in study designs.
  • A priori selection of clinically relevant subgroups based on effect modification and prevalence.
  • Utilizing equivalence testing to evaluate generalizability (absence of effect modification).

Main Results:

  • Treatment effect modification is expected, contrary to common study designs.
  • Generalizability can be statistically evaluated by defining it as the absence of effect modification.
  • When generalizability is not confirmed, further analyses are needed for tailored treatments.

Conclusions:

  • Clinical study results should account for expected treatment effect modification.
  • Tailoring treatments to patient subgroups enhances personalized medicine.
  • Quantifying evidence on effect modification is crucial for robust clinical decision-making.

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
324
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
19
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
530
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
279
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
383